Terms: = Germ cell tumor AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
274 results:
1. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
2. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/erk signalling axis.
Wang Y; Wang B; Cao W; Xu X
Biochem Biophys Res Commun; 2024 Apr; 703():149665. PubMed ID: 38359612
[TBL] [Abstract] [Full Text] [Related]
3. Neuroendocrine and squamous cell phenotypes of NUT carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma.
Ninomiya H; Sato Y; Inamura K; Dobashi A; Takeuchi K; Mitani H; Mun M; Nishio M; Ishikawa Y
Diagn Pathol; 2024 Feb; 19(1):27. PubMed ID: 38326851
[TBL] [Abstract] [Full Text] [Related]
4. Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics.
Sokolov D; Sharda N; Banerjee A; Denisenko K; Basalious EB; Shukla H; Waddell J; Hamdy NM; Banerjee A
Curr Pharm Des; 2024; 30(1):31-47. PubMed ID: 38151840
[TBL] [Abstract] [Full Text] [Related]
5. STING promotes invasion and migration of uveal melanoma through p38‑MAPK signaling.
Zhou X; Meng F; Xu B; Ma R; Cheng Y; Wu J; Qian J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099424
[TBL] [Abstract] [Full Text] [Related]
6. The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma.
Li M; Hu Y; Wang J; Xu Y; Hong Y; Zhang L; Luo Q; Zhen Z; Lu S; Huang J; Zhu J; Zhang Y; Que Y; Sun F
Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38063204
[TBL] [Abstract] [Full Text] [Related]
7. RICH2 decreases the mitochondrial number and affects mitochondrial localization in diffuse low-grade glioma-related epilepsy.
Zhang J; Gong L; Zhu H; Sun W; Tian J; Zhang Y; Liu Q; Li X; Zhang F; Wang S; Zhu S; Ding D; Zhang W; Yang C
Neurobiol Dis; 2023 Nov; 188():106344. PubMed ID: 37926169
[TBL] [Abstract] [Full Text] [Related]
8. Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.
Beyer GV; Hueser S; Li R; Manika D; Lee M; Chan CHF; Howe JR; Ear PH
Surgery; 2024 Mar; 175(3):605-612. PubMed ID: 37914572
[TBL] [Abstract] [Full Text] [Related]
9. Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma.
Wang C; Liu X; Guo S
BMC Complement Med Ther; 2023 Oct; 23(1):371. PubMed ID: 37865727
[TBL] [Abstract] [Full Text] [Related]
10. A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response.
Duan WW; Yang LT; Liu J; Dai ZY; Wang ZY; Zhang H; Zhang X; Liang XS; Luo P; Zhang J; Liu ZQ; Zhang N; Mo HY; Qu CR; Xia ZW; Cheng Q
CNS Neurosci Ther; 2024 Apr; 30(4):e14489. PubMed ID: 37850692
[TBL] [Abstract] [Full Text] [Related]
11. Knockdown of neurotrophin receptor-interacting melanoma-associated antigen homolog inhibits acute myeloid leukemia cell growth via the erk pathway.
Zhang H; Wu G; Chen B
Chin J Physiol; 2023; 66(4):276-283. PubMed ID: 37635487
[TBL] [Abstract] [Full Text] [Related]
12. Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment.
Guo T; Wu C; Zhou L; Zhang J; Wang W; Shen Y; Zhang L; Niu M; Zhang X; Yu R; Liu X
J Transl Med; 2023 Aug; 21(1):532. PubMed ID: 37550679
[TBL] [Abstract] [Full Text] [Related]
13. [Lactate-induced up-regulation of PLEKHA4 promotes proliferation and apoptosis of human glioma cells].
Ye J; Xu W; Xi B; Wang N; Chen T
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1071-1080. PubMed ID: 37488789
[TBL] [Abstract] [Full Text] [Related]
14. Chronic stress accelerates glioblastoma progression via DRD2/erk/β-catenin axis and Dopamine/erk/TH positive feedback loop.
Wang Y; Wang X; Wang K; Qi J; Zhang Y; Wang X; Zhang L; Zhou Y; Gu L; Yu R; Zhou X
J Exp Clin Cancer Res; 2023 Jul; 42(1):161. PubMed ID: 37415171
[TBL] [Abstract] [Full Text] [Related]
15. Adamantinoma-Like Ewing Sarcoma Mimicking Merkel cell Carcinoma in the Parotid Gland: A Diagnostic Pitfall.
Saikia K; Alruwaii FI; Wu V; Keller C; Chitale D; Al-Obaidy KI
Int J Surg Pathol; 2024 Feb; 32(1):115-118. PubMed ID: 37128815
[TBL] [Abstract] [Full Text] [Related]
16. INHBB promotes tumor aggressiveness and stemness of glioblastoma via activating EGFR signaling.
Yang X; Jia Q; Zou Z; Liu X; Li X; Chen H; Ma H; Chen L
Pathol Res Pract; 2023 May; 245():154460. PubMed ID: 37116368
[TBL] [Abstract] [Full Text] [Related]
17. Development of Prognostic Indicator Based on AU-Rich Elements-Related Genes in Glioblastoma.
Chen X; Xu Y; Wang M; Ren C
World Neurosurg; 2023 Jul; 175():e601-e613. PubMed ID: 37030479
[TBL] [Abstract] [Full Text] [Related]
18. Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis.
Goenka A; Song X; Tiek D; Iglesia RP; Lu M; Zeng C; Horbinski C; Zhang W; Hu B; Cheng SY
Neuro Oncol; 2023 Sep; 25(9):1592-1604. PubMed ID: 36988488
[TBL] [Abstract] [Full Text] [Related]
19. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
20. Rab32 promotes glioblastoma migration and invasion via regulation of erk/Drp1-mediated mitochondrial fission.
Chen P; Lu Y; He B; Xie T; Yan C; Liu T; Wu S; Yeh Y; Li Z; Huang W; Zhang X
Cell Death Dis; 2023 Mar; 14(3):198. PubMed ID: 36922509
[TBL] [Abstract] [Full Text] [Related]
[Next]
